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ABSTRACT 
Objective: To induce growth of a neomeniscus into the pores of a 
prosthesis in order to protect the knee joint cartilage. Methods: 
70 knees of 35 New Zealand rabbits were operated. The rab-
bits were five to seven months old, weighed 2 to 3.8 kilograms, 
and 22 were male and 13 were female. Each animal underwent 
medial meniscectomy in both knees during a single operation. A 
bioabsorbable polymeric meniscal prosthesis composed of 70% 
polydioxanone and 30% L-lactic acid polymer was implanted in 
one side. The animals were sacrificed after different postopera-
tive time intervals. The femoral condyles and neomeniscus were 
subjected to histological analysis. Histograms were used to mea-
sure the degradation and absorption of the prosthesis, the growth 
of meniscal tissue in the prosthesis and the degree of degradation 
of the femoral condyle joint cartilage. Results: The data obtained 
showed that tissue growth histologically resembling a normal 
meniscus occurred, with gradual absorption of the prosthesis, 
and the percentages of chondrocytes on the control side and 
prosthesis side. Conclusion: Tissue growth into the prosthesis 
pores that histologically resembled the normal rabbit meniscus 
was observed. The joint cartilage of the femoral condyles on 
the prosthesis side presented greater numbers of chondrocytes 
in all its layers. 
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INTRODUCTION
It has long been known that meniscectomy on the hu-
man knee has medium and long-term harmful effects, es-
pecially considering that the force distribution becomes 
significantly modified. The contact area decreases, there-
by producing increased concentration of contact forces in 
a smaller area. This may accelerate degeneration of the 
joint surface, thus resulting in early osteoarthrosis(1-5).
In the absence of better alternatives, meniscal inju-
ries have been treated over the years purely and simply 
by removing the meniscus, independent of the type and 
duration of the injury or the patients’ activities and ages. 
Young, physically very active patients who are sports 
players sometimes injure the meniscus so badly that there 
is no way out other that total meniscectomy. 
Over the last 25 years, particularly since the advent of 
arthroscopy, many authors have shown concern regard-
ing meniscus salvage(6-10).
Different techniques have been used over recent de-
cades with the aim of preserving the healthy parts of 
menisci. Sutures, transplants and meniscal prostheses 
have been among these. Tissue engineering suggests a 
very promising future. As new knowledge within the 
fields of medical genetics, immunology, biochemistry 
and bioengineering is acquired, further alternatives for 
treating various human diseases are emerging.
Research on the use of meniscal prostheses com-
posed of nontoxic, biocompatible and bioabsorbable 
material seems to be a field of great interest, since this 
brings the hope of mechanical protection for knee joint 
cartilage following loss of the menisci. If such hopes 
were proven, these patients’ joints would present greater 
longevity, with better quality of life for them.
The aim of this study, which was conducted on rab-
bits, was to evaluate the growth of a neomeniscus into 
the pores of a meniscal prosthesis and the degree of 
© 2010 Sociedade Brasileira de Ortopedia e Traumatologia. Open access under CC BY-NC-ND license.
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Figure 1 – A) On the right, a polymeric membrane and cutting performed using the puncture tool; on the left, two prostheses after 
cutting them out. B) On the right, a meniscal prosthesis; on the left, a rabbit’s normal medial meniscus
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protection given to the joint cartilage of the medial fe-
moral condyle. This prosthesis was developed from a 
membrane composed of bioabsorbable polymers. With 
degradation of the prosthesis, its components would be 
absorbed, thereby making room for the growth of fibro-
cartilaginous tissue that would histologically resemble 
the normal medial meniscus of rabbits.
METHODS
Rabbits
Operations were performed on 70 knees of 35 New 
Zealand rabbits of ages ranging from five to seven mon-
ths and weights from two to 3.8 kilograms. There were 
22 males and 13 females. Two groups were formed. In 
group A, consisting of 17 rabbits, arthrotomy and jux-
tacapsular medial meniscectomy were performed on the 
left knee, while the right knee received these procedures 
plus implantation of a meniscal prosthesis. In group 
B, with 18 rabbits, the implant was inserted in the left 
knee, while the right knee only received arthrotomy and 
medial meniscectomy.
Prosthesis
The prosthesis implanted was composed of a poly-
meric mixture of 70% polydioxanone and 30% L-lactic 
acid polymer, with 3% sodium triethyl citrate as a plas-
ticizer. The prostheses were individually packed in small 
envelopes and were sterilized with ethylene oxide.
Prosthesis manufacture and characteristics
To manufacture the prosthesis, pieces of PDS®1 su-
ture thread of 2 cm in length were cut and placed in a 
solution of methylene chloride at room temperature. 
This solution was stirred mechanically for 24 hours, in 
order to extract its violet pigmentation. The resulting 
polymer [poly(p-dioxanone)] was dissolved in 6 ml of 
hexafluoroisopropanolol (HFIP) solvent at room tempe-
rature and was stirred mechanically for one hour. The 
other polymer used in the composition of the prosthesis 
was poly(L-lactic acid)®2, which was obtained commer-
cially in liquid form.
The two polymeric solutions were mixed and stirred 
for a further hour, until completely homogenized. The 
plasticizer sodium triethyl citrate was then added, with 
stirring for another hour. The final mixture was poured 
into a glass mold of 1,500 mm2 in area (50 x 30 mm) and 
was left to evaporate slowly in an evaporating chamber 
overnight, in order to form a thin porous membrane. 
This membrane was then dried under vacuum until the 
solvent had completely evaporated. It was then cut using 
a puncturing instrument into half-moon shapes with the 
following dimensions: length of 0.8 cm along the longi-
tudinal axis, width of 0.4 cm along the transverse axis 
and thickness of 1 mm uniformly along the entire length 
(Figure 1).
Surgical technique
The animals were kept under absolute fasting con-
ditions for 12 hours before the operation. They were 
subjected to general anesthesia, with intramuscular ad-
ministration of 5% ketamine hydrochloride at a dose of 
30 mg/kg of weight, in association with 2% xylazine at 
a dose of 3 mg/kg of weight and atropine at a dose of 
0.2 mg/kg de peso. The area of the incision was shaved 
immediately before starting the surgical procedure.
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Figure 2 – Implantation and fixation of the prosthesis to the capsu-
le margin, using two stitches of 5-0 monofilament nylon thread
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The rabbits were positioned on an appropriate sur-
gical table, in horizontal dorsal decubitus. Asepsis was 
performed using a 50% iodated alcohol solution, applied 
by means of sterile gauze. The surgeon and surgical 
assistant both used sterile surgical gloves and surgical 
instruments sterilized in an autoclave at 120ºC.
An anterior medial parapatellar surgical access was 
made longitudinally in both knees, of around 5 cm in 
length, followed by dissection of the subcutaneous tis-
sue, medial parapatellar capsulotomy, lateral displace-
ment of the extensor apparatus of the knee (quadrici-
pital tendon, patella and patellar ligament), transverse 
sectioning of the medial collateral ligament at the joint 
interline and juxtacapsular resection of the medial me-
niscus, without damaging the joint cartilage of the fe-
moral condyles. The polymeric meniscal prosthesis was 
implanted in one of the knees. Fixation of the implant 
was done by means of two simple stitches of 5-0 nylon 
monofilament thread: one in the anterior portion of the 
prosthesis and the other in the middle portion, with su-
turing to the juxtacapsular soft tissue that was inserted 
in the tibia (Figure 2).
a Micropore adhesive bandage around the knee four 
times. Ampicillin was administered intramuscularly at a 
dose of 100 mg/kg of weight, as antimicrobial prophyla-
xis during the immediate postoperative period.
Postoperative follow-up
Immediately after the operation, the animals were 
housed in the vivarium, in suspended individual cages. 
They received commercial feed and water ad libitum, 
but were not given any medication. All the rabbits were 
able to support themselves on their hind legs a few hours 
after coming out of anesthesia.
Sacrifice technique and tissue collection
The rabbits received an injection of sodium pentobar-
bital at a dose of 100 mg/kg of weight intramuscularly 
and were then placed in a chloroform box.
After death had been confirmed (paralytic mydriasis 
and cessation of heartbeats respiratory movements), the 
animals were positioned in horizontal dorsal decubi-
tus on a surgical table. The hind legs were shaved and 
asepsis was performed using 50% iodated alcohol. The 
joint was accessed using a lateral parapatellar route, 
thereby avoiding the scare from the original operation, 
while taking care not to damage the joint cartilage of 
the medial femoral condyle.
Longitudinal osteotomy was performed between the 
condyles of the femur, thus removing the medial condy-
le from both knees, along with the neomeniscus that had 
resulted from tissue growth in the prosthesis. The ma-
terial collected was immediately placed in individually 
identified glass receptacles containing Bouin solution.
Histological analysis method
The specimens were processed, and the slides were 
stained using Masson’s trichrome and picrosirius and 
were then examined under an ordinary optical micros-
cope. The slides containing the neomeniscus were used 
to investigate whether new tissue growth had occurred 
in and among the pores of the polymeric prosthesis and 
what degree of prosthesis degradation and reabsorp-
tion had occurred. The slides containing the femoral 
condyles were used to perform histometry, by means 
of automated computer software for counting cells*. 
Through this method, the percentages of chondrocytes 
in the femoral condyles were determined, both on the 
side with the prosthesis implanted and on the control 
side. All the histological analyses were performed by 
an independent investigator.
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After washing with physiological serum, the medial 
collateral ligament was repaired and the capsule was 
closed using separate stitches of 5-0 nylon monofila-
ment thread. The skin was closed using continuous sti-
tches, with the same thread as used for the sutures. The 
postoperative dressing consisted of sterile gauze soaked 
in 50% iodated alcohol, which was covered by wrapping 
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Figure 3 – Example of automated computed histogram
Figure 4 – Cross-section through prosthesis (P), three weeks 
after implantation. Start of the process of prosthesis degradation 
and invasion by tissue. Note the presence of a giant foreign-body 
cell (arrow). Masson’s trichrome, 170 x
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Histometry
The slides stained with Masson’s trichrome and picro-
sirius containing sections through the femoral condyles, 
both on the control side and on the prosthesis side, i.e. 
with and without the prosthesis implant, were photogra-
phed individually and analyzed using automated com-
puter software (HLImage++97 – Histogram Tool API 
Western Vision Software, L.C., 1997 – version 2.0.0.0) 
in order to count the percentage of extracellular matrix, 
thereby also making it possible to establish the percen-
tage of chondrocytes present in the joint cartilage of the 
condyle (Figure 3).
In the sixth week, greater degradation and invasion 
of the connective tissue were observed in 100% of 
the specimens.
Tissue growth resembling that of the normal menis-
cus of rabbit knees was also observed, with the presence 
of collagen and fibrochondrocytes, although the latter 
had not yet become aligned with the collagen fibers.
Neomeniscus
Three weeks after the implantation, invasion of con-
nective tissue was observed, thereby dividing the pros-
thesis into smaller units that had not yet been degraded. 
These smaller fragments were spherulites. The presence 
of giant foreign-body cells was also observed (Figure 4). 
The Figure shows a computer screen image from a 
histogram that was obtained by photographing a slide 
containing a section through the joint surface of a rabbit’s 
femoral condyle. The extracellular matrix is stained bla-
ck, although in this software it is indicated as gray. The 
white arrow shows the number 0.906, which signifies 
90.6% extracellular matrix. The percentage of chon-
drocytes (which are seen in white on the photograph, 
with some examples marked by circles) is equal to the 
difference between the two parts (matrix and cells). In 
this case, the percentage of cells is 9.4% (chondrocytes), 
here seen in white, and would be equal to the difference, 
i.e. to 9.4%. Since the software counts the extracellular 
matrix, there is no false counting of chondrocytes.
RESULTS
All the prostheses implanted underwent a process 
of gradual degradation and absorption, which could be 
seen starting from the third week after implantation. 
There were still no typical cells of normal menisci (Fi-
gure 5). The white region seen in Figure 6 represents 
parts of the prosthesis that had not yet become degraded. 
These birefringent regions were composed of spherulites 
from the prosthesis, surrounded by collagen fibers.
The spherulites were only observed under polari-
zed light, because of the difference in refractive index 
between the crystalline and amorphous regions. There 
were still no typical cells of normal menisci.
Six weeks after implantation, intense degradation 
of the material was seen, and consequently, greater 
tissue invasion than seen after three weeks (Figure 7). 
It was still not possible to see any fibrochondrocytes. 
Under polarized light, the fragments of the prosthesis 
were seen to be more widely dispersed, as represented 
by the bright regions in the photo (Figure 8). After 
12 weeks, the prosthesis and giant foreign-body cells 
could still be seen on some slides (Figure 9). On other 
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Figure 5 – Cross-section through a rabbit’s meniscus, showing 
fibrochondrocytes dispersed throughout an extracellular matrix 
and the orientation pattern of the collagen fibers (arrow). Mas-
son’s trichrome, 200 x
Figure 6 – Cross-section through the prosthesis three weeks 
after implantation. Note the presence of spherulites (E) relating 
to the degraded polymer and collagen fibers. With polarization. 
Picrosirius, 170 x
Figure 7 – Cross-section through the prosthesis six weeks after 
implantation. Note the intense degradation and greater tissue 
invasion. Masson’s trichrome, 170 x
Figure 8 – Cross-section through the prosthesis six weeks after implan-
tation. Note the greater dispersion of polymer fragments, as represented 
by the bright regions in the photo. With polarization. Picrosirius, 170 x
Figure 9 – Cross-section through the prosthesis, 12 weeks after 
implantation, showing complete invasion by connective tissue. 
Note the presence of giant foreign-body cells (arrows). Masson’s 
trichrome, 425 x
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slides, the prosthesis could not be discerned, but fibro-
cartilage was seen, albeit with poorly aligned collagen 
fibers (Figure 10).
Macroscopic appearance
Three weeks after implantation, the prosthesis pre-
sented a yellowish macroscopic appearance, with ge-
latinous consistency (Figure 11). From the sixth week 
onwards, the consistence was seen to be firmer and re-
sistant to manipulation (Figure 12).
After 12 weeks, the neomeniscus had a firm consis-
tency and was fibrocartilaginous, with a color resem-
bling that of normal menisci (Figure 13 ).
Femoral condyles
The histological analysis on the joint cartilage of the 
femoral condyle on the side with the implanted polyme-
ric prosthesis showed that invasion of connective tissue 
had occurred, with many chondrocytes along the entire 
length of the prosthesis, three weeks after implantation. 
In the control condyle, three weeks after the operation, 
the chondrocytes were located more internally. The most 
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Figure 10 – Cross-section through the prosthesis, 12 weeks after 
implantation, showing only the presence of fibrocartilage. Mas-
son’s trichrome, 290 x
Figure 11 – Macroscopic appearance of a rabbit’s knee three 
weeks after implantation of a polymeric prosthesis (arrows). The 
implant has a yellowish gelatinous appearance and consistency
Figure 12 – Macroscopic appearance of the neomeniscus formed 
from the implanted prosthesis, after six weeks (arrows). Firmer 
consistency, resistant to manipulation
Figure 13 – Macroscopic appearance of the neomeniscus formed 
from the prosthesis, 12 weeks after implantation (arrows). The 
neomeniscus has a firm consistency, fibrocartilaginous appearance 
and color that resemble the characteristics of normal menisci
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superficial layer of the cartilage presented signs of cell 
disarrangement and greater concentration of collagen 
fibers (Figures 14 and 15).
After six weeks, it was seen that the control condyle 
presented chondrocytes in the deeper layers, while the 
most superficial layer presented dense connective tissue 
that was practically acellular. On the other hand, after 
six weeks, the condyle with the implanted prosthesis 
presented chondrocytes distributed more equally across 
all the layers (Figures 16 and 17).
Twelve weeks after implantation, the control con-
dyle presented a larger number of chondrocytes in the 
more internal layers, with an appearance of cell di-
sarrangement on the joint surface. The distribution of 
chondrocytes in the cartilage of the condyle with the 
prosthesis was more homogenous and better organized, 
in all layers (Figures 18 and 19).
STATISTICAL ANALYSIS**
The distribution of absolute frequencies (n) and rela-
tive frequencies (%) of the nominal characteristics (qua-
litative) or enumerative data (attributes) was analyzed 
in relation to sex (male or female), side that received 
the prosthesis (right or left) and presence of fibrochon-
drocytes in the neomeniscus (absent or present).
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Figure 14 – Condyle on control side, three weeks after operation, 
presenting few chondrocytes, which are located more internally. Note 
large accumulation of collagen fibers. Masson’s trichrome, 50 x
Figure 15 – Condyle on prosthesis side, three weeks after the 
operation, presenting large numbers of chondrocytes in all layers. 
Masson’s trichrome, 50 x
Figure 16 – Control condyle, six weeks after the operation, pre-
senting few chondrocytes, located more internally, and dense 
connective tissue more superficially. Masson’s trichrome, 50 x
Figure 17 – Condyle on prosthesis side, six weeks after the 
operation, presenting many chondrocytes in all layers of the con-
dyle. Masson’s trichrome, 50 x
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** The statistical terminology and definitions were used in accordance with the GUIA PARA EXPRESSÃO DA INCERTEZA DE MEDIÇÃO, Second Brazilian 
Edition of the Guide to the Expression of Uncertainty in Measurement (BIPM, IEC, IFCC, ISSO, IUPAC, IUPAP, OIML, 1983). Revised Edition (August 1998) – 
Rio de Janeiro: ABNT, INMETRO, SBM, 1998.
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Figure 18 – Condyle on control side, 12 weeks after the opera-
tion, presenting more chondrocytes in the interior than on the 
joint surface. Masson trichrome, 50 x
Figure 19 – Condyle on prosthesis side, 12 weeks after the 
operation, presenting similar quantities of chondrocytes on the 
joint surface and in the matrix. Picrosirius, 50 x
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Figure 20 – Distribution of relative frequencies (%) of the presence of 
fibrochondrocytes in the histological sections from the neomeniscus, 
according to the time elapsed since implantation, in weeks
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The frequencies of occurrence of each attribute (quality) 
according to the groups of three weeks, six weeks and twel-
ve weeks (time since implantation) and the TOTAL (gene-
ral), were presented in contingency tables. The proportions 
(%) in the groups were represented by pie charts.
To analyze specific magnitudes (variables), descrip-
tive statistics of the ordinal (quantitative) characteristics 
were produced: mean (M), standard deviation (SD), stan-
dard effort of the mean (SEM), maximum value (MAX), 
minimum value (MIN) and number of cases (N).
Scientific rounding was used, and the results were 
presented with up to two decimal places or until the 
first significant number. The confidence level of 5% 
was used (A = 0.05). In the tables, proven statistical 
differences were shown by asterisks (*).
The descriptive statistics on magnitudes according to 
the groups (samples) of three weeks, six weeks and twelve 
weeks, and between controls and prosthesis use, were pre-
sented in statistical tables and represented in bar graphs.
In comparisons between frequencies of classes, in 
relation to the presence of fibrochondrocytes in the 
neomeniscus, the chi-square test could not be applied 
because the number of cells in the range from < 5 to 0 
was greater than the permitted level. It was decided to 
investigate the difference between the groups of twelve 
weeks (final) and three weeks (initial) using Fisher’s 
exact test (Table 1 and Figure 20).
In comparisons between the two groups (control and 
prosthesis) regarding the nonparametric variables of per-
centages of chondrocytes (%) at three, six and twelve 
weeks, the Mann-Whitney U test was used (Tables 2, 3 
and 4 and Figures 21, 22 and 23).
Table 1 – Distribution of absolute frequencies (n) and relative 
frequencies (%) of the presence of fibrochondrocytes in histo-
logical sections from the neomeniscus, according to the time 
elapsed since implantation (three, six and 12 weeks). Compari-
son between three and 12 weeks according to Fisher’s exact 
test (A = 0.05)
Presence of fibrochondrocytes in the neomeniscus
3 weeks 6 weeks 12 weeks Total
n % n % n % n %
Absent 8 34.8 4 17.4 0 0.0 12 32.2
Present 1 4.3 4 17.4 6 26.1 11 47.8
Total 9 39.1 8 34.8 6 26.1 231 100.0
123 rabbits evaluated out of the 35 initial rabbits, due to loss of slides
Fisher p = 0.001*
3 WEEKS
88,9%
11,1%
12 WEEKS
100,0%
6 WEEKS
50,0%50,0%
ABSENT PRESENT
Table 2 – Descriptive statistics on the maximum percentage of 
chondrocytes (%) observed in the cartilage of the femoral con-
dyles, in the various histological sections from each condyle, with 
or without prosthesis (neomeniscus), three weeks after implanta-
tion. Comparison using the Mann-Whitney U test (A = 0.05)
Percentage of chondrocytes (%) after 3 weeks
Control Prosthesis
M 20.46 29.42
SD 2.38 11.72
SEM 1.07 4.78
MAX 22.9 48.2
MIN 17.6 15.8
N 5 6
Mann-Whitney U Uc = 3 U = 9.0 p > 0.05
Figure 21 – Maximum percentage of chondrocytes (%) observed in the 
cartilage of the femoral condyles, in the various histological sections from 
each condyle, with or without prosthesis (neomeniscus), three weeks 
after implantation
3 WEEKS
20,46
29,42
0
10
20
30
40
Group
M
e
a
n
Control Prosthesis
Table 3 – Descriptive statistics on the maximum percentage of 
chondrocytes (%) observed in the cartilage of the femoral con-
dyles, in the various histological sections from each condyle, with 
or without prosthesis (neomeniscus), six weeks after implantation. 
Comparison using the Mann-Whitney U test (A = 0.05) 
Percentage of chondrocytes (%) 
after 6 weeks
Control Prosthesis
M 10.81 19.23
SD 0.53 6.87
SEM 0.20 2.81
MAX 11.5 29.5
MIN 10.2 11.7
N 7 6
Mann-Whitney U Uc = 6 U = 0.0 p < 0.05*
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In comparisons between the three groups regarding 
the nonparametric variables of percentage of chon-
drocytes (%) in condyles without a prosthesis (controls) 
(Table 5 and Figure 24) and percentage of chondrocytes 
(%) in the condyles with a prosthesis (neomeniscus) 
(Table 6 and Figure 25), the Kruskal-Wallis test was 
used and the significant differences were discriminated 
using the multiple comparisons test modified by Dunn 
(Table 5 and Figure 24).
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Figure 22 – Maximum percentage of chondrocytes (%) observed in the 
cartilage of the femoral condyles, in the various histological sections 
from each condyle, with or without prosthesis (neomeniscus), six weeks 
after implantation
6 WEEKS
10,81
19,23
0
5
10
15
20
25
Group
M
e
a
n
Control Prosthesis
Table 4 – Descriptive statistics on the maximum percentage of 
chondrocytes (%) observed in the cartilage of the femoral con-
dyles, in the various histological sections from each condyle, with 
or without prosthesis (neomeniscus), 12 weeks after implantation. 
Comparison using the Mann-Whitney U test (A = 0.05)
Percentage of chondrocytes (%) after 12 weeks
Control Prosthesis
M 11.30 16.13
SD 1.01 3.00
SEM 0.45 1.73
MAX 12.6 19.6
MIN 10.2 14.3
N 5 3
MANN-WHITNEY U UC = 0.0 U = 0.0 P < 0.05*
Figure 23 – Maximum percentage of chondrocytes (%) observed 
in the cartilage of the femoral condyles, in the various histological 
sections from each condyle, with or without prosthesis (neome-
niscus), 12 weeks after implantation 
12 WEEKS
11,3
16,13
0
5
10
15
20
Group
M
e
a
n
Control Prosthesis
Table 5 – Descriptive statistics on the maximum percentage of 
chondrocytes (%) observed in the cartilage of the femoral con-
dyles on the side without a prosthesis (control), in the various 
histological sections from each condyle, according to the time 
elapsed since implantation (three, six and 12 weeks). Compari-
son using the Kruskal-Wallis test and discrimination using the 
multiple comparisons test modified by Dunn (A = 0.05) 
Percentage of chondrocytes (%) in the condyle without a 
prosthesis (control)
3 weeks 6 weeks 12 weeks
M 20.46 10.81 11.30
SD 2.38 0.53 1.01
SEM 1.07 0.20 0.45
MAX 22.9 11.5 12.6
MIN 17.6 10.2 10.2
N 5 7 5
Kruskal-Wallis H = 10.4 p = 0.006*
Dunn  3 weeks > 6 weeks
Figure 24 – Maximum percentage of chondrocytes (%) observed in the 
cartilage of the femoral condyles on the side without a prosthesis (con-
trol), in the various histological sections from each condyle, according to 
the time elapsed since implantation, in weeks
Control group
10,81 11,3
20,46
0
5
10
15
20
25
Weeks
M
e
a
n
3 6 12
Table 6 – Descriptive statistics on the maximum percentage of 
chondrocytes (%) observed in the cartilage of the femoral con-
dyles on the side with a prosthesis (neomeniscus), in the various 
histological sections from each condyle, according to the time 
elapsed since implantation (three, six and 12 weeks). Comparison 
using the Kruskal-Wallis test (A = 0.05)
Percentage of chondrocytes (%) in the condyle with a 
prosthesis (neomeniscus)
3 weeks 6 weeks 12 weeks
M 29.42 19.23 16.13
SD 11.72 6.87 3.00
SEM 4.78 2.81 1.73
MAX 48.2 29.5 19.6
MIN 15.8 11.7 14.3
N 6 6 3
Kruskal-Wallis H = 5.27 p = 0.07
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DISCUSSION
For many years, little or no importance was given 
to menisci, and the treatment for meniscal injuries was 
limited to meniscectomy(11-13).
In 1897, the Englishman Bland-Sutton apud 
Annandale(11) stated that menisci were structures origi-
nating from leg muscle remnants and did not have any 
function.
At the end of the seventeenth century, the English 
surgeon Thomas Annandale apud AAOS(12) published 
an article in the British Medical Journal, in which he 
demonstrated concern regarding meniscal salvage. A 
few years later, his compatriot Sir Robert Jones(13), who 
at that time was an orthopedist of worldwide renown, 
criticized his colleague’s position and declared that su-
turing the meniscal cartilage should be considered to be 
an obsolete operation.
Menisci have a half-moon shape: their upper sur-
face (which is in contact with the femoral condyle) is 
concave, while their lower surface (in contact with the 
tibia) is slightly convex. This annuls the geometrical 
incongruence of the knee bone anatomy(12,14).
They are composed of connective tissue with few 
cells, distributed in an abundant extracellular matrix 
composed of collagen (approximately 60% to 70% of 
their dry weight), proteoglycans, glycoproteins, elastin 
and water(12).
Among its important functions, it distributes the 
forces on the joint cartilage, absorbs shocks during dy-
namic loading and probably helps in joint lubrication. 
It adapts well to weight support, especially in areas of 
loading and movement such as the synovial joints(12).
Group with prosthesis
29,42
19,23
16,13
0
5
10
15
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M
e
a
n
3 6 12
Figure 25 – Maximum percentage of chondrocytes (%) observed 
in the cartilage of the femoral condyles on the side with a pros-
thesis (neomeniscus), in the various histological sections from 
each condyle, according to the time elapsed since implantation, 
in weeks
The menisci of the knee are poorly vascularized 
structures. The vascularization decreases from the 
peripheral insertion at the edge of the capsule to the 
joint center(15-18).
The longest time for maintaining the implant was 
defined as twelve weeks because the transformation of 
fibrocytes into fibrochondrocytes occurs at the end of 
this period(19-22).
Rabbits were chosen for our study because they are 
animals that are easy to manage, very resistant to infec-
tions and of an adequate size for carrying out the expe-
riment. The large number of studies conducted around 
the world using these animals also contributed towards 
this choice(5,7,18,20,23-34).
In the pilot study by Pezzin(35), mechanical traction 
tests on membranes composed of 80% poly(para-dio-
xanone) and 20% poly(L-lactic acid), which were ob-
tained by means of solvent evaporation, showed that 
these were the membranes with the lowest modulus of 
rigidity and that therefore this mixture had the greatest 
flexibility.
The term polymer comes from Greek: poly means 
many and meres means parts. Polymers are macromo-
lecules formed by repeated united known as monomers. 
One of the best known examples is polyethylene, which 
is composed of repeated ethylene molecules.
Conceptually, biodegradable polymers are those that 
undergo degradation through vital activity by the orga-
nism, while bioabsorbable polymers undergo a process 
of hydrolysis by body fluids, which leads to their gra-
dual absorption.
Biomaterials such as biodegradable and bioabsorba-
ble polymers have a growing role within the therapeutic 
arsenal of medicine. Suture threads, skin replacements, 
growth guides for nerves and vessels and orthopedic 
devices such as plates and screws can be cited. Exam-
ples of these include Dexon® suture thread, composed 
of poly(glycolic acid) and PDS® (polydioxanone suture), 
composed of poly(para-dioxanone).
Certain criteria need to be respected with regard to 
implanting biomaterial in the human body. Among the-
se, the material needs to be nontoxic, have an adequate 
absorption rate and present low immunological, carci-
nogenic and thrombogenic responses(36).
Polymeric membranes that are proposed for use as 
meniscal prostheses have to meet criteria relating to 
porosity, biocompatibility, mechanical resistance, fle-
xibility, shape or geometrical design, and adequacy of 
size and composition for allowing tissue growth among 
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the membrane pores. The porosity needs to be such that 
it allows invasion and fixation of biological tissue. The 
relationship between the sizes of the pores and the in-
vading cells is very important(34,36-42).
Concern regarding the treatment of meniscal lesions 
and particularly in relation to meniscal salvage, thereby 
saving knees, goes back a long time(5,8,11,20).
Several methods have been used. The following can be 
highlighted: partial or selective meniscectomy(2,6,12,14,43-49), 
use of synovial flaps(7,25,27,28,32,50), use of different repla-
cement tissues(37,50-53), meniscal sutures(6,7,9-11,12,14,43,46-48), 
meniscal transplants(16,23,51,53-60) and meniscal prostheses 
(16,30,31,34,37,38,61-63).
Each of these methods presents advantages and di-
sadvantages. Partial meniscectomy occasionally resects 
a significant portion of the meniscus, thus leaving a 
very large dead space. On the other hand, when it is 
done far from the peripheral insertion of the capsule 
of the meniscus, no regeneration of meniscal tissue is 
achieved, probably because of the vascularization cha-
racteristics.
The use of synovial flaps seems to fulfill a role in 
inducing growth of meniscal tissue, but only in small 
defects or as a bridge between the juxtacapsular syno-
vium and lesions that are more central.
The use of heterologous grafts is subject to an impor-
tant problem of rejection by the receptor organism. The 
results from using tissues with functions differing from 
those of the meniscus, such as tendons, even if they are 
homologous or autologous, do not seem to be encoura-
ging, particularly with regard to mechanical results.
Meniscal sutures are limited to small or recent margi-
nal lesions, i.e. those located in the zone of best vascu-
larization that are smaller than 1.3 centimeters in length 
and which occurred less than two or three months ago. 
Different techniques and artifacts have been studied, 
such as suturing from inside to outside, versus from 
outside to inside; and fixation using polymer darts.
Transplants, along with prostheses, are perhaps the 
most promising form of treatment. There are still some 
unresolved problems regarding immunological matters 
and the methods for sterilization and preoperative eva-
luation of the correct size for the transplant(59). It is im-
portant to bear in mind that donor availability, like in 
relation to other organs and tissues, is still an obstacle 
to success for these methods.
The first meniscal transplant was performed by Mi-
lachowski et al in 1984(57). Through refinement of the 
technique and the indication criteria, the results have 
improved and it can now be said that this procedure is 
studied investigatively rather than experimentally. The 
difference in considering a study to be investigative is 
that some degree of success is implied, although not as 
predictably as would be desired.
Wickiewicz et al(60) performed the first arthroscopic 
meniscal transplant and presented a study on 96 cases 
with ten years of postoperative follow-up in which the 
failure rate was almost 50%. They stated that the main 
reason for this was that cases with moderate to severe ar-
throsis had been included. Careful selection of candidates 
for meniscal transplantation is very important.
Another important point is that the graft should be of 
the appropriate size. The sides (left or right), the com-
partment (medial or lateral) and the weight and height 
of the donor and receptor need to be noted. The way in 
the grafts are preserved and stored is also very important, 
given that some sterilization methods involving irradia-
tion weaken the grafts. It is certainly recommendable to 
perform the surgery as early as possible, while the ar-
throtic changes are still not very severe. It seems unlikely 
that severe degenerative osteoarthrosis could be reversed 
through implantation of a meniscal graft(60).
Studies on prostheses have included different types of 
materials with a wide variety of results. There have been 
attempts to use polyurethane(37), Teflon(64), collagen(61-63), 
polyester(34), carbon fiber(32,34,65), Dacron(30,31) and combi-
nations of these materials(30,31,65). Carbon fiber prostheses 
almost always induce synovitis and cause problems that 
are difficult to resolve. Materials like Dacron, Teflon and 
polyester are abrasive, probably because of their high 
degree of rigidity, and do not facilitate cell growth. The 
use of Teflon does not impede the appearance of arthrotic 
abnormalities(64).
It seems that none of these prostheses restores the 
normal biomechanics of the knees. Nor do they impede 
the appearance of arthrotic abnormalities. Prostheses pro-
duced using collagen molds allow tissue growth better 
than do others that have been investigated. They cause 
fewer problems for the joint cartilage, but still have the 
problem of immunogenicity. Nonetheless, this seems to 
be a path to be investigated.
The aim of our study was evaluate the degree of 
degradation and reabsorption  of the prosthesis and the 
growth of a neomeniscus.
We were able to confirm that the joint cartilage of the 
medial femoral condyle was in some manner protected 
by the prosthesis, given that greater numbers of chon-
drocytes could be seen in all layers of the cartilage on 
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the side in which the device was implanted, compared 
with the control side.
The statistical analysis demonstrated that, three we-
eks after the implantation, there was no difference in the 
percentages of chondrocytes on the control and prosthe-
sis sides. On the other hand, after six and twelve weeks, 
the percentage of chondrocytes on the prosthesis side 
was greater than on the control side.
In the statistical analysis on the femoral condyles, 
we observed that there was a greater decrease in the 
percentage of cartilaginous cells on the side without a 
prosthesis, compared with the side with an implanted 
prosthesis. Thus, there was greater degeneration of the 
cartilage and therefore greater degenerative osteoarthro-
sis on the control side, which coincides with previous 
findings in the literature(1-3,5,66).
Our results suggest that polymeric prostheses present 
great potential for replacing the meniscus. We believe 
that porous polymeric prostheses are certainly one of 
the alternatives for prophylactic treatment of seconda-
ry osteoarthrosis in the human knee. This treatment is 
clinically applicable especially for young athletes who 
suffer severe and irreparable meniscal injuries.
We believe that in the future, porous polymeric 
molded prostheses should be one of the alternatives 
for prophylactic treatment of secondary osteoarthrosis, 
following trauma to the human knee, with important 
clinical application in preventing this pathological con-
dition, particularly among young patients with severe 
meniscal injuries.
It is likely that polymeric membranes are going to play 
an essential role in structuring molded prostheses that ena-
ble the construction of tissues and organs from patients’ 
own cells. This will make it possible to have solutions that 
are more biological and less aggressive, with regard to a 
range of pathological conditions.
Tissue engineering will probably change the history 
of medicine in the near future, and polymers will be 
part of this.
CONCLUSIONS
Polymeric prostheses undergo gradual degradation 1 –  
and absorption.
Tissue growth takes place into the pores of the pros-2 –  
thesis, with histological characteristics resemble those 
of rabbits’ normal menisci.
The joint cartilage of the femoral condyles on the 3 –  
side with the implanted prosthesis present greater num-
bers of chondrocytes, in all layers.
The joint cartilage of the femoral condyles on the 4 –  
side without the implant presents fewer chondrocytes, 
particularly in the most superficial layer.
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